bullish
Square Pharmaceuticals (SQUARE BD): Recent Policy Changes Open Up International Opportunities
181 Views27 Feb 2022 23:00
SUMMARY
- Square Pharmaceuticals (SQUARE BD) has received permission from the Bangladesh Bank to invest overseas, after the government issued new rules for overseas investment.
- Per initial plan, Square Pharmaceuticals will invest $1 million in Philippines, which is the third largest ASEAN region. The company’s Kenya manufacturing facility is expected to start production soon.
- During H1FY22, Square Pharmaceuticals revenue growth of 17% outpaced the industry growth. The company generated higher net margin than its closest competitors.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Square Pharmaceuticals (SQUARE BD): Recent Policy Changes Open Up International Opportunities27 Feb 2022
- Square Pharmaceuticals (SQUARE BD): Too Many Competitors Spoil the Party for Covid-19 Oral Drug29 Nov 2021
x